News Focus
News Focus
icon url

DewDiligence

03/15/08 6:35 PM

#9205 RE: DewDiligence #9181

MM-093 Addressable Market in RA
In the US, there are about 200,000
patients who use biologics in the
second- and third-line settings.



Source: Genentech